Tag: kidney graft rejection
New urine test could explain kidney transplant rejections
The day when a urine test can inform a doctor precisely why a kidney transplant patient is experiencing organ rejection, and help to suggest...
New guideline supports kidney exchange programmes and “integrated approach” in sensitised...
A new guideline on the management of highly sensitised kidney transplant patients—those who have high levels of human leukocyte antigens (HLAs) and are therefore more...
SGLT2 inhibitors demonstrate efficacy and safety in diabetic kidney transplant recipients
Sodium-glucose cotransporter-2 (SGLT2) inhibitors can be used safely to help preserve graft function in diabetic kidney transplant recipients, as per the findings from a...
Machine learning fails to outperform traditional models in predicting long-term allograft...
A study presented at this year’s American Transplant Congress (ATC; 4–8 June, Boston, USA) found that machine learning (ML) technologies did not outperform traditional...
Talaris announces positive kidney graft acceptance findings from FREEDOM-1 study
Talaris Therapeutics today provided a clinical update on its ongoing phase 3 FREEDOM-1 study of FCR001—the company's investigational allogeneic cell therapy designed to induce...
CareDx expands portfolio with new AI-based tool for predicting kidney allograft...
CareDx recently announced that it plans to expand its growing multimodality portfolio with AiKidney—a new clinical decision support tool for allograft risk assessment that...
Natera showcases new data on Prospera and Renasight tests at American...
Natera today announced the presentation of data on the clinical utility of its Prospera and Renasight tests across a total of 14 sessions at...
First patient dosed in study evaluating TX200 cell therapy product for...
Sangamo Therapeutics has announced dosing of the first patient in the Phase 1/2 STEADFAST clinical study evaluating TX200—an investigational, wholly owned, autologous chimeric antigen...
NephroSant launches two-year AQUA study involving 2,000 kidney transplant recipients
NephroSant has today announced enrolment of the first patient in its AQUA (Assessment of QSant for underlying allograft rejection) study. Eligible participants will have...
NephroSant publishes real-world data on potential of QSant test in kidney...
NephroSant has announced that the Journal of Clinical Medicine has published real-world data that provides insight into how changes in allograft health are reflected in...
Bio-Techne announces development and license agreement with Thermo Fisher Scientific for...
Bio-Techne has announced an agreement with Thermo Fisher Scientific to exclusively complete the development of and commercialise the ExoTRU kidney transplant rejection test developed...
Natera announces study results showing “excellent” positive predictive value of Prospera...
Natera has announced the results of a large clinical experience study confirming the "strong performance" of its Prospera donor-derived cell-free DNA (dd-cfDNA) test in...
Lifestyle changes can be critical for kidney transplant patients’ long-term survival
Cancer, infections and heart disease pose the greatest risk to kidney transplant recipients—not organ rejection—according to a recently published Mayo Clinic study. Researchers discovered...
Promising histological marker of kidney graft failure identified by new study
An observational study published in the Journal of the American Society of Nephrology (JASN) has identified a “promising” histological marker for determining kidney transplant...
Natera validates kidney transplant rejection test in multicentre, prospective Trifecta study
Natera has announced initial results from the global, multicentre, prospective Trifecta study, which assessed its Prospera with quantification test for kidney transplant rejection and was led by Phil...